ppharmПедиатрическая фармакологияPediatric pharmacology1727-57762500-3089Издательство «ПедиатрЪ»10.15690/pf.v10i5.819ppharm-171Research ArticleОБЗОР ЛИТЕРАТУРЫREVIEWСОВРЕМЕННЫЕ МЕТОДЫ ЛЕЧЕНИЯ УГРЕВОЙ БОЛЕЗНИ У ДЕТЕЙMODERN METHODS OF ACNE TREATMENT IN CHILDRENНосачёваО. А.NosachyovaO. A.

аспирант кафедры факультетской педиатрии № 1 Российского национального исследовательского медицинского университета им. Н.И. Пирогова, врач-дерматолог консультативно-диагностического центра Научного центра здоровья детей РАМН

PhD candidate of the faculty pediatric department #1 at the Pirogov Russian National Medical Research University, dermatologist of the consultative and diagnostic center at the Scientific Center of Children’s Health

nosachevanczd@yandex.ruТоршхоеваР. М.TorshkhoevaR. M.Намазова-БарановаЛ. С.TorshkhoevaR. M.Российский национальный исследовательский медицинский университет им. Н.И. Пирогова Научный центр здоровья детей РАМН, МоскваРоссияScientific Center of Children’s Health, Moscow Pirogov Russian National Medical Research UniversityRussian FederationНаучный центр здоровья детей РАМН, Москва, Российская Федерация Первый Московский государственный медицинский университет им. И.М. Сеченова Минздрава, Российская ФедерацияРоссияScientific Center of Children’s Health, Moscow, Russian Federation First Sechenov Moscow State Medical University of the Ministry of Health, Russian FederationRussian FederationНаучный центр здоровья детей РАМН, Москва, Российская Федерация Первый Московский государственный медицинский университет им. И.М. Сеченова Минздрава, Российская Федерация Российский национальный исследовательский медицинский университет им. Н.И. Пирогова, МоскваРоссияScientific Center of Children’s Health, Moscow, Russian Federation First Sechenov Moscow State Medical University of the Ministry of Health, Russian Federation Pirogov Russian National Medical Research University, MoscowRussian Federation201301102013105Педиатрическая фармакология2330Copyright © Носачёва О.А., Торшхоева Р.М., Намазова-Баранова Л.С., 20132013Носачёва О.А., Торшхоева Р.М., Намазова-Баранова Л.С.Nosachyova O.A., Torshkhoeva R.M., Torshkhoeva R.M.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.pedpharma.ru/jour/article/view/171

The article is dedicated to one of the relevant issues of childhood and adolescence – acne. It describes modern approaches to acne treatment, including local, systemic and combined therapy and physiotherapeutic treatment methods. The article also presents foreign and Russian data on the use of different groups of drugs for acne therapy and peculiarities of acne treatment in pediatric practice.

 

угревая болезньакнелечениедетиподросткиacnetreatmentchildrenadolescentsReferencesMancini A. J., Baldwin H. E., Eichenfield L. F. et al. Acne life cycle: the spectrum of pediatric disease. Seminars in cutaneous medicine and surgery. 2011; 30: S2–5.Mancini A. J., Baldwin H. E., Eichenfield L. F. et al. Acne life cycle: the spectrum of pediatric disease. Seminars in cutaneous medicine and surgery. 2011; 30: S2–5.Henderson M., Abboud J., Cogan C. M. et al. Skin-of-Color Epidemiology: A Report of the Most Common Skin Conditions by Race. Pediatric Dermatology. 2012. Doi: 10.1111/j.1525- 1470.2012.01775.xHenderson M., Abboud J., Cogan C. M. et al. Skin-of-Color Epidemiology: A Report of the Most Common Skin Conditions by Race. Pediatric Dermatology. 2012. Doi: 10.1111/j.1525- 1470.2012.01775.xSathakis V., Kilkenny M., Marks R. et al. Descriptive epidemiology of acne vulgaris in the community. Australas J Dermatol. 1997; 38: 115.Sathakis V., Kilkenny M., Marks R. et al. Descriptive epidemiology of acne vulgaris in the community. Australas J. Dermatol. 1997; 38: 115.Webster G. F. Acne vulgaris. BMJ. 2002; 325: 475–9.Webster G. F. Acne vulgaris. BMJ. 2002; 325: 475–479.Krakowski A. C., Eichenfield L. F. Pediatric acne: clinical presentations, evaluation, and management. J Drugs Dermatol. 2007; 6: 584–588.Krakowski A. C., Eichenfield L. F. Pediatric acne: clinical presentations, evaluation, and management. J. Drugs Dermatol. 2007; 6: 584–588.Bowe W., Logan A. Acne vulgaris, probiotics and the gut-brainskin axis — back to the future? Gut Pathogens. 2011; 3: 1–12.Bowe W., Logan A. Acne vulgaris, probiotics and the gut-brainskin axis — back to the future? Gut Pathogens. 2011; 3: 1–12.Papageorgiou P., Katsambas A., Chu A. Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris. Br J Dermatol. 2000; 142: 973–8.Papageorgiou P., Katsambas A., Chu A. Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris. Br. J. Dermatol. 2000; 142: 973–8.Gollnick H., Cunliffe W., Berson D. et al. Management of acne: a report from Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003; 49 (Suppl.): S1–37.Gollnick H., Cunliffe W., Berson D. et al. Management of acne: a report from Global Alliance to Improve Outcomes in Acne. J. Am. Acad. Dermatol. 2003; 49 (Suppl.): S1–37.Haider A., Shaw J. Treatment of acne vulgaris. JAMA. 2004; 292: 726–35.Haider A., Shaw J. Treatment of acne vulgaris. JAMA. 2004; 292: 726–35.Owczarek W., Wydrzynska A., Paluchowska E. Antibiotic therapy in skin diseases. Pol Merkur Lekarski. 2011; 179: 367–72.Owczarek W., Wydrzynska A., Paluchowska E. Antibiotic therapy in skin diseases. Pol. Merkur. Lekarski. 2011; 179: 367–72.Lucky A. W. A review of infantile and pediatric acne. Dermatology. 1998; 196: 95–97.Lucky A. W. A review of infantile and pediatric acne. Dermatology. 1998; 196: 95–97.Gollnick H., Cunliffe W., Berson D. et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003; 49: S1–37.Gollnick H., Cunliffe W., Berson D. et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J. Am. Acad. Dermatol. 2003; 49: 1–37.Eichenfield L. F., Alio Saenz A. B. Safety and efficacy of clindamycin phosphate 1,2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study. J Drugs Dermatol. 2011; 12: 1382–96.Eichenfield L. F., Alio Saenz A. B. Safety and efficacy of clindamycin phosphate 1,2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study. J. Drugs Dermatol. 2011; 12: 1382–1396.Langner A., Sheehan-Dare R., Layton A. A randomized, singleblind comparison of topical clindamycin + benzoyl peroxide (Duac) and erythromycin + zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris. J Eur Acad Dermatol Venereol. 2007; 3: 311–9.Langner A., Sheehan-Dare R., Layton A. A randomized, singleblind comparison of topical clindamycin + benzoyl peroxide (Duac) and erythromycin + zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris. J Eur. Acad. Dermatol. Venereol. 2007; 3: 311–399.Yentzer B. A., Irby C. E., Fleischer A. B. et al. Differences in acne treatment prescribing patterns of pediatricians and dermatologists: An analysis of nationally representative data. Pediatr Dermatol. 2008; 25: 635–639.Yentzer B. A., Irby C. E., Fleischer A. B. et al. Differences in acne treatment prescribing patterns of pediatricians and dermatologists: An analysis of nationally representative data. Pediatr. Dermatol. 2008; 25: 635–639.Babaeinejad S., Khodaeiani E., Fouladi R. F. Comparison of therapeutic effects of oral doxycycline and azithromycin in patientswith moderate acne vulgaris: What is the role of age? J Dermatolog Treat. 2011; 4: 206–10.Babaeinejad S., Khodaeiani E., Fouladi R. F. Comparison of therapeutic effects of oral doxycycline and azithromycin in patients with moderate acne vulgaris: What is the role of age? J. Dermatolog. Treat. 2011; 4: 206–210.Burkhart C. G., Burkhart C. N. Treatment of acne vulgaris without antibiotics: tertiary amine-benzoyl peroxide combination vs. benzoyl peroxide alone (Proactiv Solution). Int J Dermatol. 2007; 46: 89–93.Burkhart C. G., Burkhart C. N. Treatment of acne vulgaris without antibiotics: tertiary amine-benzoyl peroxide combination vs. benzoyl peroxide alone (Proactiv Solution). Int. J. Dermatol. 2007; 46: 89–93.Bardazzi F., Savoia F., Parente G. et al. Azithromycin: a new therapeutical strategy for acne in adolescents. Dermatol Online J. 2007; 13 (4): 4.Bardazzi F., Savoia F., Parente G. et al. Azithromycin: a new therapeutical strategy for acne in adolescents. Dermatol. Online J. 2007; 13 (4): 4.Matiz C., Funk A., Eichenfield L. et al. An open-label study to assess the efficacy and tolerability of tretinoin gel microsphere 0,04% in a pump dispenser in early and preadolescents. American Academy of Dermatology 68th Annual Meeting Abstract Book Abstract, March 5–9. 2010. P. 714.Matiz C., Funk A., Eichenfield L. et al. An open-label study to assess the efficacy and tolerability of tretinoin gel microsphere 0,04% in a pump dispenser in early and preadolescents. American Academy of Dermatology 68th Annual Meeting Abstract Book Abstract, March 5–9. 2010. p. 714.Jorizzo J., Grossman R., Nighland M. Tretinoin microsphere gel in younger acne patients. J Drugs Dermato. 2008; 7: S9–13.Jorizzo J., Grossman R., Nighland M. Tretinoin microsphere gel in younger acne patients. J. Drugs Dermatol. 2008; 7: S9–13.Hodgkiss-Harlow C. J., Eichenfield L. F., Dohil M. A. Effective monitoring of isotretinoin safety in a pediatric dermatologypopulation: a novel «patient symptom survey» approach. J Am Acad Dermatol. 2011; 65 (3): 517–24.Hodgkiss-Harlow C. J., Eichenfield L. F., Dohil M. A. Effective monitoring of isotretinoin safety in a pediatric dermatology population: a novel «patient symptom survey» approach. J. Am. Acad. Dermatol. 2011; 65 (3): 517–524.Misery L., Feton-Danou N., Consoli A. et al. Isotretinoin and adolescent depression. Ann Dermatol Venereol. 2012; 139 (2): 118–23.Misery L., Feton-Danou N., Consoli A. et al. Isotretinoin and adolescent depression. Ann. Dermatol. Venereol. 2012; 139 (2): 118–23.Chia C. Y., Lane W., Chibnall J. et al. Isotretinoin therapy and mood changes in adolescents with moderate to severe acne: a cohort study. Arch Dermatol. 2005; 141: 557–60.Chia C. Y., Lane W., Chibnall J. et al. Isotretinoin therapy and mood changes in adolescents with moderate to severe acne: a cohort study. Arch. Dermatol. 2005; 141: 557–60.Hello M., Prey S., Leґauteґ-Labreze C. Infantile Acne: A Retrospective Study of 16 Cases. Pediatric Dermatology. 2008; 25 (4): 434–438.Hello M., Prey S., Leґauteґ-Labreze C. Infantile Acne: A Retrospective Study of 16 Cases. Pediatric Dermatology. 2008; 25 (4): 434–438.Barnes C. J., Eichenfield L. F., Lee J. et al. A practical approach for the use of oral isotretinoin for infantile acne. Pediatr Dermatol. 2005; 22: 166–169.Barnes C. J., Eichenfield L. F., Lee J. et al. A practical approach for the use of oral isotretinoin for infantile acne. Pediatr. Dermatol. 2005; 22: 166–169.Yan A., Baldwin H., Eichenfield L. Approach to Pediatric Acne Treatment: An Update. Semin Cutan Med Surg. 2011; 30: S16–21.Yan A., Baldwin H., Eichenfield L. Approach to Pediatric Acne Treatment: An Update. Semin. Cutan Med. Surg. 2011; 30: S16–21.Kjeldstad B., Johnsson A. An action spectrum for blue and near ultraviolet inactivation of Propionibacterium acnes; with emphasis on a possible porphyrin photosensitization. Photochem Photobiol. 1986; 43: 67–70.Kjeldstad B., Johnsson A. An action spectrum for blue and near ultraviolet inactivation of Propionibacterium acnes; with emphasis on a possible porphyrin photosensitization. Photochem. Photobiol. 1986; 43: 67–70.Sigurdsson V., Knulst A. C., van Weelden H. Phototherapy of acne vulgaris with visible light. Dermatology. 1997; 194: 256–60.Sigurdsson V., Knulst A. C., van Weelden H. Phototherapy of acne vulgaris with visible light. Dermatology. 1997; 194: 256–60.Meffert H., Gaunitz K., Gutewort T. et al. Therapy of acne with visible light. Decreased irradiation time by using a blue-light high-energy lamp. Dermatol Monatsschr. 1990; 176: 597–603.Meffert H., Gaunitz K., Gutewort T. et al. Therapy of acne with visible light. Decreased irradiation time by using a blue-light high-energy lamp. Dermatol. Monatsschr. 1990; 176: 597–603.Wiegell S. R., Wulf H. C. Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolevulinate. J Am Acad Dermatol. 2006; 54: 647–51.Wiegell S. R., Wulf H. C. Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolevulinate. J. Am. Acad. Dermatol. 2006; 54: 647–51.Wiegell S. R., Wulf H. C. Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: a blinded, randomized, controlled trial. Br J Dermatol. 2006; 154: 969–76.Wiegell S. R., Wulf H. C. Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: a blinded, randomized, controlled trial. Br. J. Dermatol. 2006; 154: 969–76.Hong S. B., Lee M. H. Topical aminolevulinic acid-photodynamic herapy for the treatment of acne vulgaris. Photodermatol Photoimmunol Photomed. 2005; 21: 322–5.Hong S. B., Lee M. H. Topical aminolevulinic acid-photodynamic therapy for the treatment of acne vulgaris. Photodermatol Photoimmunol Photomed. 2005; 21: 322–5.Yeung C. K., Shek S. Y., Bjerring P. et al. A comparative study of intense pulsed light alone and its combination with photodynamic therapy for the treatment of facial acne in Asian skin. Lasers Surg Med. 2007; 39: 1–6.Yeung C. K., Shek S. Y., Bjerring P. et al. A comparative study of intense pulsed light alone and its combination with photodynamic therapy for the treatment of facial acne in Asian skin. Lasers Surg. Med. 2007; 39: 1–6.Haedersdal M., Togsverd-Bo K., Wiegell S. R. et al. Long-pulsed dye laser versus long-pulsed dye laser-assisted photodynamic therapy for acne vulgaris: a randomized controlled trial. J Am Acad Dermatol. 2008; 58: 387–94.Haedersdal M., Togsverd-Bo K., Wiegell S. R. et al. Long-pulsed dye laser versus long-pulsed dye laser-assisted photodynamic therapy for acne vulgaris: a randomized controlled trial. J. Am. Acad. Dermatol. 2008; 58: 387–94.Taub A. F. A comparison of intense pulsed light, combination radiofrequency and intense pulsed light, and blue light in photodynamic therapy for acne vulgaris. J Drugs Dermatol. 2007; 6: 1010–16.Taub A. F. A comparison of intense pulsed light, combination radiofrequency and intense pulsed light, and blue light in photodynamic therapy for acne vulgaris. J. Drugs Dermatol. 2007; 6: 1010–16.Chang S. E., Ahn S. J., Rhee D. Y. et al. Treatment of acne papules and pustules in Korean patients using an intense pulsed light device equipped with a 530-to 750-nm filter. Dermatol Surg. 2007; 33: 676–9.Chang S. E., Ahn S. J., Rhee D. Y. et al. Treatment of acne papules and pustules in Korean patients using an intense pulsed light device equipped with a 530-to 750-nm filter. Dermatol Surg. 2007; 33: 676–9.Gold M. H., Rao J., Goldman M. P. et al. A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution. J Drugs Dermatol. 2005; 4: 64–70.Gold M. H., Rao J., Goldman M. P. et al. A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution. J. Drugs Dermatol. 2005; 4: 64–70.Baugh W. P., Kucaba W. D. Nonablative phototherapy for acne vulgaris using the KTP 532 nm laser. Dermatol Surg. 2005; 31: 1290–6.Baugh W. P., Kucaba W. D. Nonablative phototherapy for acne vulgaris using the KTP 532 nm laser. Dermatol. Surg. 2005; 31: 1290–6.Na J. I., Suh D. H. Red light phototherapy alone is effective for acne vulgaris: randomized, single-blinded clinical trial. Dermatol Surg. 2007; 33: 1228–33.Na J. I., Suh D. H. Red light phototherapy alone is effective for acne vulgaris: randomized, single-blinded clinical trial. Dermatol. Surg. 2007; 33: 1228–33.Rojanamatin J., Choawawanich P. Treatment of inflammatory facial acne vulgaris with intense pulsed light and short contact of topical 5-aminolevulinic acid: a pilot study. Dermatol Surg. 2006; 32: 991–6.Rojanamatin J., Choawawanich P. Treatment of inflammatory facial acne vulgaris with intense pulsed light and short contact of topical 5-aminolevulinic acid: a pilot study. Dermatol. Surg. 2006; 32: 991–6.Иванов О. Л., Халдин А. А., Кочергин Н. Г., Монахов С. А. Применение полихроматического некогерентного поляризованного света в дерматологии, косметологии и эстетической медицине. Методические рекомендации. Пособие для врачей. М., 2008.Ivanov O. L., Khaldin A. A., Kochergin N. G., Monakhov S. A. Primenenie polikhromaticheskogo nekogerentnogo polyarizovannogo sveta v dermatologii, kosmetologii i esteticheskoi meditsine. Metodicheskie rekomendatsii. Posobie dlya vrachei [Application of Polychromatic Incoherent Polarized Light in Dermatology, Cosmetology and Aesthetic Medicine. Methodical Recommendations.Guideline]. Moscow, 2008.Yentzer B. A., Gosnell A. L., Clark A. R. et al. A randomized controlled pilot study of strategies to increase adherence in teenagers with acne vulgaris. J Am Acad Dermatol. 2011; 64 (4): 793–5.Yentzer B. A., Gosnell A. L., Clark A. R. et al. A randomized controlled pilot study of strategies to increase adherence in teenagers with acne vulgaris. J. Am. Acad. Dermatol. 2011; 64 (4): 793–5.Richards H. L., Fortune D. G. et al. Adherence to treatment in patients with psoriasis. J Eur Acad Dermatol Venereol. 2006; 20: 370–379.Richards H. L., Fortune D. G. et al. Adherence to treatment in patients with psoriasis. J. Eur. Acad. Dermatol. Venereol. 2006; 20: 370–379.Носачева О. А., Каркашадзе Г. А., Намазова-Баранова Л. С. Психоэмоциональное состояние детей и подростков с угревой болезнью. Педиатрическая фармакология. 2012; 4: 42–47.Nosacheva O. A., Karkashadze G. A., Namazova-Baranova L. S. Pediatricheskaya farmakologiya = Pediatric pharmacology. 2012; 4: 42–47.Ellis R., Koch L. et al. Potential Barriers to Adherence in Pediatric Dermatology. Pediatr Dermatol. 2011; 28 (3): 242–4.Ellis R., Koch L. et al. Potential Barriers to Adherence in Pediatric Dermatology. 2011; 28 (3): 242–4.

The authors declare that there are no conflicts of interest present.